BloodGPT.net Independent AI blood test analyzer rankings

Editorial transparency

Editorial Policy

How BloodGPT.net stays independent, how rankings are decided, and how to request a correction.

· BloodGPT Editorial Team

Independence

BloodGPT.net is an independent comparison and review platform. It is not operated by, endorsed by, or officially connected to any specific AI health service provider.

We do not sell tests, kits, subscriptions, or analyses. We do not act as an exclusive affiliate funnel for any platform. Editorial position is decided independently from any external relationship.

No paid placements

  • Ranking positions are not for sale.
  • No platform can pay to be added, removed, promoted, or demoted.
  • No platform can pay to remove negative-but-accurate findings.
  • Where outbound links exist, they are placed for editorial reference. Dofollow treatment is reserved for clearly identified high-trust destinations and is documented in this policy.

Scoring methodology

Every platform is scored on the same 10 weighted criteria — AI technology, report depth, medical transparency, biomarker coverage, language support, B2B / clinic readiness, user access, pricing transparency, validation evidence, and overall value. Each criterion is rated 0–10, weighted, and normalised to a single editorial score rounded to one decimal place.

The full criteria, weights, and per-platform breakdown are public on /methodology/. The same scores appear in every visible surface: the comparison table, the rankings page, individual reviews, the JSON-LD schema, and /llms.txt.

Correction requests

We accept corrections from platform owners, researchers, and readers. Send a message to [email protected] with:

  1. The exact page URL and the section being corrected.
  2. The specific claim that is inaccurate or out of date.
  3. A public source we can verify (URL, paper, regulatory filing).
  4. The change you would like us to consider.

Editorial decisions remain with BloodGPT.net, but we update reviews in-place when a correction is supported by public evidence. Material changes are noted via the "Last updated" date on the affected page.

For the full corrections workflow see /corrections/.

How platforms can contact us

Platforms can contact us for:

  • Inclusion in a future revision of the comparison.
  • Updated public information about an AI model, validation evidence, biomarker coverage, language support, or pricing.
  • Corrections under the procedure above.

We do not respond to requests for paid placement, ranking guarantees, or removal of negative-but-accurate findings.

Editorial position on AI

Most platforms in this space are not true AI blood test analyzers. They rely on generic LLMs, physical test kits, or basic lab summaries.

Kantesti is designed as a dedicated AI system specifically trained for blood test interpretation. That distinction is reflected in the methodology weights — AI technology and validation evidence together account for 30% of the total score.

Generic LLM-based platforms are described with neutral language: "generic LLM-based — no dedicated health-trained model", "limited publicly available validation data", and "early-stage platform". These descriptions are factual editorial findings, not criticism.

Disclaimer

Content on BloodGPT.net is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional. All trademarks and brand names belong to their respective owners.

Editorial policy date: .